Identifying potential core genes for chronic obstructive pulmonary disease associated with cocaine exposure via

Wei Luo1, Ming-Ke He2, Mao-Run Guo3

  • 1School of Health and Wellness & School of Medicine, Sichuan University of Arts and Science, Dazhou, Sichuan 635000, People's Republic of China.

Insights

Cocaine use may contribute to chronic obstructive pulmonary disease (COPD) by affecting cathepsin D (CTSD). This study identifies CTSD as a key molecular target linking cocaine exposure to COPD, offering a basis for further research.

Area of Science:

  • Computational biology
  • Toxicology
  • Pulmonology

Background:

  • Cocaine abuse is linked to organ damage, but its connection to chronic obstructive pulmonary disease (COPD) is unclear.
  • Molecular mechanisms linking cocaine exposure to COPD pathogenesis require elucidation.

Purpose of the Study:

  • To investigate molecular links between cocaine exposure and COPD using an integrative computational framework.
  • To identify key molecular targets and regulatory mechanisms involved in cocaine-induced COPD.

Main Methods:

  • Collected and analyzed cocaine-associated targets and COPD-related differentially expressed genes (DEGs).
  • Utilized functional enrichment, protein-protein interaction networks, and machine learning algorithms.
  • Performed single-cell RNA sequencing, virtual knockout analysis, molecular docking, and molecular dynamics simulations.

Main Results:

  • Identified 34 overlapping DEGs between cocaine exposure and COPD, enriched in cancer, inflammation, and virus pathways.
  • Highlighted cathepsin D (CTSD) as a core target highly expressed in macrophages, potentially linking cocaine and COPD.
  • Demonstrated strong binding affinity between cocaine and CTSD, suggesting a mechanistic role and identifying potential therapeutic drugs.

Conclusions:

  • CTSD is a candidate molecular target connecting cocaine exposure to COPD.
  • This study provides a theoretical foundation for experimental and toxicological investigations into cocaine-related COPD.